These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34042293)

  • 21. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.
    Natsuizaka M; Whelan KA; Kagawa S; Tanaka K; Giroux V; Chandramouleeswaran PM; Long A; Sahu V; Darling DS; Que J; Yang Y; Katz JP; Wileyto EP; Basu D; Kita Y; Natsugoe S; Naganuma S; Klein-Szanto AJ; Diehl JA; Bass AJ; Wong KK; Rustgi AK; Nakagawa H
    Nat Commun; 2017 Nov; 8(1):1758. PubMed ID: 29170450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma.
    Zhao Y; Wang N; Zhang X; Liu H; Yang S
    J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T
    Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
    Iguchi T; Ueda M; Masuda T; Nambara S; Kidogami S; Komatsu H; Sato K; Tobo T; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Oncology; 2018; 95(3):179-187. PubMed ID: 29909415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
    Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
    Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
    Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.
    Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B
    Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2.
    Li J; Sang M; Zheng Y; Meng L; Gu L; Li Z; Liu F; Wu Y; Li W; Shan B
    Exp Cell Res; 2021 Dec; 409(1):112891. PubMed ID: 34688610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA‑485‑5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin‑1 and inhibits the epithelial‑mesenchymal transition.
    Zhao R; Shan Y; Zhou X; Zhang C; Zhao R; Zhao L; Shan B
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
    Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
    Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
    Zhai Y; Shan C; Zhang H; Kong P; Zhang L; Wang Y; Hu X; Cheng X
    Mol Cell Biochem; 2022 Dec; 477(12):2689-2702. PubMed ID: 35606602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.